While Teladoc Health Inc has overperformed by 2.90%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TDOC fell by -17.93%, with highs and lows ranging from $15.21 to $6.35, whereas the simple moving average fell by -7.51% in the last 200 days.
On November 13, 2025, BMO Capital Markets started tracking Teladoc Health Inc (NYSE: TDOC) recommending Market Perform. A report published by Mizuho on July 25, 2025, Initiated its previous ‘Neutral’ rating for TDOC. Goldman also rated TDOC shares as ‘Buy’, setting a target price of $14 on the company’s shares in an initiating report dated November 15, 2024. Jefferies Reiterated the rating as Hold on September 17, 2024, but set its price target from $8 to $10. Cantor Fitzgerald initiated its ‘Overweight’ rating for TDOC, as published in its report on February 29, 2024. Leerink Partners’s report from February 26, 2024 suggests a price prediction of $17 for TDOC shares, giving the stock a ‘Market Perform’ rating. DA Davidson also rated the stock as ‘Neutral’.
Analysis of Teladoc Health Inc (TDOC)
Further, the quarter-over-quarter decrease in sales is -2.20%, showing a negative trend in the upcoming months.
One of the most important indicators of Teladoc Health Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -15.42% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.52, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and TDOC is recording 7.53M average volume. On a monthly basis, the volatility of the stock is set at 5.60%, whereas on a weekly basis, it is put at 5.30%, with a gain of 6.57% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.11, showing growth from the present price of $7.46, which can serve as yet another indication of whether TDOC is worth investing in or should be passed over.
How Do You Analyze Teladoc Health Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.10%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 70.56% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
